News | April 02, 2009

VOLCANO Integrates FFR on All Major Cardiovascular Angiography Systems

April 2, 2009 - Volcano Corp. this week at ACC 2009 announced the availability of its integrated fractional flow reserve (FFR) technology on all major cardiovascular X-ray systems.

Interest in the use of FFR, a guidewire-based technology that helps assess a lesion’s severity based on the amount of blood flow through the lesion, has increased significantly since the release of the multi-center randomized FAME (FFR vs. Angiography for Multivessel Evaluation) data in late 2008 and publication in the New England Journal of Medicine in January 2009. FAME demonstrated FFR-guidance in routine multi-vessel PCI resulted in clinically-superior outcomes and reduced the composite of death, documented myocardial infarction, and repeat revascularization by 30 percent at one year. The study also demonstrated that these improved clinical outcomes were complemented by significantly reduced cost to the hospitals involved in the trial.

Volcano’s integrated FFR technology can be purchased as part of its s5i system, offering clinicians access to IVUS and FFR at the patient bedside. Volcano has relationships with each of the major cardiovascular X-ray companies to facilitate the installation of the s5i with integrated FFR in any cath lab.

Volcano said it experienced an FFR growth of 36 percent in Q4 2008 versus Q4 2007 and that physicians are increasingly relying on FFR to help guide PCI procedures.

Volcano's integrated s5i was on display at the 2009 ACC meeting in Orlando at the company’s booth as well as in the booths of GE, Philips, Siemens and Toshiba.

For more information: www.volcanocorp.com

Related Content

BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | FFR Technologies| December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Videos | FFR Technologies| November 15, 2017
A discussion with William Fearon, M.D.
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | FFR Technologies| November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies| November 08, 2017
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017...
FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone. TCT 2017

FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone.

News | FFR Technologies| November 06, 2017
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a p
Acist Medical Systems Announces Approval and Launch of Next-Generation FFR System
Technology | FFR Technologies| November 03, 2017
Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini System, the next-...
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Technologies| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Technologies| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
News | FFR Technologies| May 31, 2017
Acist Medical Systems Inc. announced results from the ACIST-FFR Study demonstrating the consistent and correlative...
Overlay Init